INREBIC caps 100 mg 120 pce

7680677920011 Pharmacode 7808396 CH-67792 L01EJ02
INREBIC caps 100 mg 120 pce
INREBIC caps 100 mg 120 pce
INREBIC caps 100 mg 120 pce
INREBIC caps 100 mg 120 pce
1 / 4
Fiches Amavita / Sun Store / Coop Vitality

Details

GTIN
7680677920011
Pharmacode
7808396
Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/10/2023
Patient information leaflet
Français
10/10/2023
Patient information leaflet
Italien
10/10/2023
Professional SmPC
Allemand
10/10/2023
Professional SmPC
Français
10/10/2023
Professional SmPC
Italien
10/10/2023

Detailed composition

Substance Quantity Type Category
fedratinibum
100.0 MG Substance Wirkstoff (Principe actif)
fedratinibi dihydrochloridum monohydricum
- Substance WIZUS
cellulosum microcristallinum silicificatum
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
natrium
0.18 MG Substance HBESI
gelatina
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK
E 171
- Substance FNIDK
lacca
- Substance HNIDK
E 171
- Substance FNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Authorization holder

Bristol-Myers Squibb SA

6312 Steinhausen

Authorization information

Swissmedic authorization number
67792
Drug name
Inrebic, Hartkapseln
Galenic form
KAPS
ATC Code
L01EJ02
Authorization status
BA
Dispensation category
A
First authorization
01/07/2021
Authorization expiration date
28/02/2025
IT number
07.16.1.
Domain
Human medicine
Field of application
Primäre oder sekundäre Myelofibrose

Packaging details

Description (FR)
INREBIC caps 100 mg 120 pce
Description (DE)
INREBIC Kaps 100 mg 120 Stk
Market launch
01/07/2021
Market withdrawal
31/05/2027
Narcotic (BTM)
No
Buy us a coffee Explore the data